Vast Therapeutics
  • Home
  • About
    • Our Team
    • Scientific Advisory Board
  • Technology
    • Pipeline
    • NO Prodrugs
    • Posters/Presentations
  • Patients
    • Bronchiectasis
    • NTM Lung Disease
    • Cystic Fibrosis
    • Other Targets
  • News
  • Contact
  • Our Team

Patient Populations with Significant Unmet Need

Other Targets

​Vast is also interested in partnering to further evaluate the efficacy of its proprietary nitric oxide-release compounds against other respiratory diseases, including tuberculosis (TB), aspergillosis, hospital-acquired bacterial pneumonia (HABP), and ventilator acquired bacterial pneumonia (VABP).
Bronchiectasis >
Vast Therapeutics logo - white

Address

615 Davis Drive, Suite 800
​Morrisville, NC 27560

Contact Us

info@vasttherapeutics.com

Sector

Biopharmaceutical

Industry

​Biotechnology

    Sign Up for Email Alerts

Submit
​Forward-Looking Statement | Privacy | Terms of Use
​Copyright © 2022 Vast Therapeutics - All Rights Reserved
Picture
  • Home
  • About
    • Our Team
    • Scientific Advisory Board
  • Technology
    • Pipeline
    • NO Prodrugs
    • Posters/Presentations
  • Patients
    • Bronchiectasis
    • NTM Lung Disease
    • Cystic Fibrosis
    • Other Targets
  • News
  • Contact
  • Our Team